aluates Reports

$ 0.0

Automative

Global Autoimmune Therapeutics Drugs Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-10L14085

Global Autoimmune Therapeutics Drugs Market Research Report 2023

BUY CHAPTERS

Global Autoimmune Therapeutics Drugs Market Research Report 2025

Code: QYRE-Auto-10L14085

Report

June 2025

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Amgen Inc

Novartis

Eli Lilly and Company

Pfizer Inc

Roche Holding AG

Astrazeneca plc

Abbott Laboratories

Genentech Inc

Merck

Bayer

Biogen

GlaxoSmithKline PLC

Perrigo

Autoimmune Therapeutics Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Autoimmune Therapeutics Drugs Market

The global market for Autoimmune Therapeutics Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Autoimmune Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Therapeutics Drugs.

The Autoimmune Therapeutics Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmune Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Autoimmune Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Autoimmune Therapeutics Drugs Market Report

Report Metric	Details
Report Name	Autoimmune Therapeutics Drugs Market
CAGR	5%
Segment by Type	NSAIDs Corticosteroids Disease-Modifying Anti-Rheumatic Drugs Monoclonal Antibodies
Segment by Application	Hospitals and Clinics Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Amgen, Novartis, Eli Lilly and Company, Pfizer, Roche Holding AG, AstraZeneca, Abbott Laboratories, Genentech, Merck & Co., Bayer, Biogen, GlaxoSmithKline, Perrigo
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Therapeutics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Autoimmune Therapeutics Drugs Market report?

Ans: The main players in the Autoimmune Therapeutics Drugs Market are AbbVie, Amgen, Novartis, Eli Lilly and Company, Pfizer, Roche Holding AG, AstraZeneca, Abbott Laboratories, Genentech, Merck & Co., Bayer, Biogen, GlaxoSmithKline, Perrigo

What are the Application segmentation covered in the Autoimmune Therapeutics Drugs Market report?

Ans: The Applications covered in the Autoimmune Therapeutics Drugs Market report are Hospitals and Clinics, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Autoimmune Therapeutics Drugs Market report?

Ans: The Types covered in the Autoimmune Therapeutics Drugs Market report are NSAIDs, Corticosteroids, Disease-Modifying Anti-Rheumatic Drugs, Monoclonal Antibodies

Recommended Reports

Autoimmune Therapeutics

Drug Safety & Clinical

Neurology & Alzheimer's

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 NSAIDs

1.2.3 Corticosteroids

1.2.4 Disease-Modifying Anti-Rheumatic Drugs

1.2.5 Monoclonal Antibodies

1.3 Market by Application

1.3.1 Global Autoimmune Therapeutics Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Clinics

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Autoimmune Therapeutics Drugs Market Perspective (2020-2031)

2.2 Global Autoimmune Therapeutics Drugs Growth Trends by Region

2.2.1 Global Autoimmune Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Autoimmune Therapeutics Drugs Historic Market Size by Region (2020-2025)

2.2.3 Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2026-2031)

2.3 Autoimmune Therapeutics Drugs Market Dynamics

2.3.1 Autoimmune Therapeutics Drugs Industry Trends

2.3.2 Autoimmune Therapeutics Drugs Market Drivers

2.3.3 Autoimmune Therapeutics Drugs Market Challenges

2.3.4 Autoimmune Therapeutics Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue

3.1.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue (2020-2025)

3.1.2 Global Autoimmune Therapeutics Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Autoimmune Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Autoimmune Therapeutics Drugs Revenue

3.4 Global Autoimmune Therapeutics Drugs Market Concentration Ratio

3.4.1 Global Autoimmune Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Therapeutics Drugs Revenue in 2024

3.5 Global Key Players of Autoimmune Therapeutics Drugs Head office and Area Served

3.6 Global Key Players of Autoimmune Therapeutics Drugs, Product and Application

3.7 Global Key Players of Autoimmune Therapeutics Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Therapeutics Drugs Breakdown Data by Type

4.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Type (2020-2025)

4.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2026-2031)

5 Autoimmune Therapeutics Drugs Breakdown Data by Application

5.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Application (2020-2025)

5.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Autoimmune Therapeutics Drugs Market Size (2020-2031)

6.2 North America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)

6.4 North America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Autoimmune Therapeutics Drugs Market Size (2020-2031)

7.2 Europe Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)

7.4 Europe Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Autoimmune Therapeutics Drugs Market Size (2020-2031)

8.2 Asia-Pacific Autoimmune Therapeutics Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Autoimmune Therapeutics Drugs Market Size (2020-2031)

9.2 Latin America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)

9.4 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Autoimmune Therapeutics Drugs Market Size (2020-2031)

10.2 Middle East & Africa Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Autoimmune Therapeutics Drugs Introduction

11.1.4 AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Autoimmune Therapeutics Drugs Introduction

11.2.4 Amgen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Autoimmune Therapeutics Drugs Introduction

11.3.4 Novartis Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Eli Lilly and Company

11.4.1 Eli Lilly and Company Company Details

11.4.2 Eli Lilly and Company Business Overview

11.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Introduction

11.4.4 Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.4.5 Eli Lilly and Company Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Autoimmune Therapeutics Drugs Introduction

11.5.4 Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Roche Holding AG

11.6.1 Roche Holding AG Company Details

11.6.2 Roche Holding AG Business Overview

11.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Introduction

11.6.4 Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.6.5 Roche Holding AG Recent Development

11.7 AstraZeneca

11.7.1 AstraZeneca Company Details

11.7.2 AstraZeneca Business Overview

11.7.3 AstraZeneca Autoimmune Therapeutics Drugs Introduction

11.7.4 AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.7.5 AstraZeneca Recent Development

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Details

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Introduction

11.8.4 Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.8.5 Abbott Laboratories Recent Development

11.9 Genentech

11.9.1 Genentech Company Details

11.9.2 Genentech Business Overview

11.9.3 Genentech Autoimmune Therapeutics Drugs Introduction

11.9.4 Genentech Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.9.5 Genentech Recent Development

11.10 Merck & Co.

11.10.1 Merck & Co. Company Details

11.10.2 Merck & Co. Business Overview

11.10.3 Merck & Co. Autoimmune Therapeutics Drugs Introduction

11.10.4 Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.10.5 Merck & Co. Recent Development

11.11 Bayer

11.11.1 Bayer Company Details

11.11.2 Bayer Business Overview

11.11.3 Bayer Autoimmune Therapeutics Drugs Introduction

11.11.4 Bayer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.11.5 Bayer Recent Development

11.12 Biogen

11.12.1 Biogen Company Details

11.12.2 Biogen Business Overview

11.12.3 Biogen Autoimmune Therapeutics Drugs Introduction

11.12.4 Biogen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.12.5 Biogen Recent Development

11.13 GlaxoSmithKline

11.13.1 GlaxoSmithKline Company Details

11.13.2 GlaxoSmithKline Business Overview

11.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Introduction

11.13.4 GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.13.5 GlaxoSmithKline Recent Development

11.14 Perrigo

11.14.1 Perrigo Company Details

11.14.2 Perrigo Business Overview

11.14.3 Perrigo Autoimmune Therapeutics Drugs Introduction

11.14.4 Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)

11.14.5 Perrigo Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Amgen Inc

Novartis

Eli Lilly and Company

Pfizer Inc

Roche Holding AG

Astrazeneca plc

Abbott Laboratories

Genentech Inc

Merck

Bayer

Biogen

GlaxoSmithKline PLC

Perrigo

List of Tables

Table 1. Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of NSAIDs

Table 3. Key Players of Corticosteroids

Table 4. Key Players of Disease-Modifying Anti-Rheumatic Drugs

Table 5. Key Players of Monoclonal Antibodies

Table 6. Global Autoimmune Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Autoimmune Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Autoimmune Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Autoimmune Therapeutics Drugs Market Share by Region (2020-2025)

Table 10. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Autoimmune Therapeutics Drugs Market Share by Region (2026-2031)

Table 12. Autoimmune Therapeutics Drugs Market Trends

Table 13. Autoimmune Therapeutics Drugs Market Drivers

Table 14. Autoimmune Therapeutics Drugs Market Challenges

Table 15. Autoimmune Therapeutics Drugs Market Restraints

Table 16. Global Autoimmune Therapeutics Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Autoimmune Therapeutics Drugs Market Share by Players (2020-2025)

Table 18. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2024)

Table 19. Ranking of Global Top Autoimmune Therapeutics Drugs Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Autoimmune Therapeutics Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Autoimmune Therapeutics Drugs, Headquarters and Area Served

Table 22. Global Key Players of Autoimmune Therapeutics Drugs, Product and Application

Table 23. Global Key Players of Autoimmune Therapeutics Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Autoimmune Therapeutics Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2020-2025)

Table 27. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2026-2031)

Table 29. Global Autoimmune Therapeutics Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2020-2025)

Table 31. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2026-2031)

Table 33. North America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Autoimmune Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Autoimmune Therapeutics Drugs Product

Table 51. AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Amgen Company Details

Table 54. Amgen Business Overview

Table 55. Amgen Autoimmune Therapeutics Drugs Product

Table 56. Amgen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 57. Amgen Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Autoimmune Therapeutics Drugs Product

Table 61. Novartis Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. Eli Lilly and Company Company Details

Table 64. Eli Lilly and Company Business Overview

Table 65. Eli Lilly and Company Autoimmune Therapeutics Drugs Product

Table 66. Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 67. Eli Lilly and Company Recent Development

Table 68. Pfizer Company Details

Table 69. Pfizer Business Overview

Table 70. Pfizer Autoimmune Therapeutics Drugs Product

Table 71. Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 72. Pfizer Recent Development

Table 73. Roche Holding AG Company Details

Table 74. Roche Holding AG Business Overview

Table 75. Roche Holding AG Autoimmune Therapeutics Drugs Product

Table 76. Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 77. Roche Holding AG Recent Development

Table 78. AstraZeneca Company Details

Table 79. AstraZeneca Business Overview

Table 80. AstraZeneca Autoimmune Therapeutics Drugs Product

Table 81. AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 82. AstraZeneca Recent Development

Table 83. Abbott Laboratories Company Details

Table 84. Abbott Laboratories Business Overview

Table 85. Abbott Laboratories Autoimmune Therapeutics Drugs Product

Table 86. Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 87. Abbott Laboratories Recent Development

Table 88. Genentech Company Details

Table 89. Genentech Business Overview

Table 90. Genentech Autoimmune Therapeutics Drugs Product

Table 91. Genentech Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 92. Genentech Recent Development

Table 93. Merck & Co. Company Details

Table 94. Merck & Co. Business Overview

Table 95. Merck & Co. Autoimmune Therapeutics Drugs Product

Table 96. Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 97. Merck & Co. Recent Development

Table 98. Bayer Company Details

Table 99. Bayer Business Overview

Table 100. Bayer Autoimmune Therapeutics Drugs Product

Table 101. Bayer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 102. Bayer Recent Development

Table 103. Biogen Company Details

Table 104. Biogen Business Overview

Table 105. Biogen Autoimmune Therapeutics Drugs Product

Table 106. Biogen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 107. Biogen Recent Development

Table 108. GlaxoSmithKline Company Details

Table 109. GlaxoSmithKline Business Overview

Table 110. GlaxoSmithKline Autoimmune Therapeutics Drugs Product

Table 111. GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 112. GlaxoSmithKline Recent Development

Table 113. Perrigo Company Details

Table 114. Perrigo Business Overview

Table 115. Perrigo Autoimmune Therapeutics Drugs Product

Table 116. Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)

Table 117. Perrigo Recent Development

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Autoimmune Therapeutics Drugs Picture

Figure 2. Global Autoimmune Therapeutics Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Autoimmune Therapeutics Drugs Market Share by Type: 2024 VS 2031

Figure 4. NSAIDs Features

Figure 5. Corticosteroids Features

Figure 6. Disease-Modifying Anti-Rheumatic Drugs Features

Figure 7. Monoclonal Antibodies Features

Figure 8. Global Autoimmune Therapeutics Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Autoimmune Therapeutics Drugs Market Share by Application: 2024 VS 2031

Figure 10. Hospitals and Clinics Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Online Pharmacies Case Studies

Figure 13. Autoimmune Therapeutics Drugs Report Years Considered

Figure 14. Global Autoimmune Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Autoimmune Therapeutics Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Autoimmune Therapeutics Drugs Market Share by Region: 2024 VS 2031

Figure 17. Global Autoimmune Therapeutics Drugs Market Share by Players in 2024

Figure 18. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Therapeutics Drugs Revenue in 2024

Figure 20. North America Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)

Figure 22. United States Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)

Figure 26. Germany Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Autoimmune Therapeutics Drugs Market Share by Region (2020-2031)

Figure 34. China Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)

Figure 42. Mexico Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)

Figure 46. Turkey Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 50. Amgen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 52. Eli Lilly and Company Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 53. Pfizer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 54. Roche Holding AG Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 56. Abbott Laboratories Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 57. Genentech Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 58. Merck & Co. Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 59. Bayer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 60. Biogen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 61. GlaxoSmithKline Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 62. Perrigo Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Systemic Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune Drugs Market Insights Forecast to 2030

Localized Autoimmune Disease Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clinical Trials of Drugs and Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Multiple Sclerosis Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Autoimmune Disorder Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

AI Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions